# FDA Inspection 637079 - Novartis Pharmaceuticals Corporation - December 10, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/95ce5c10-844f-4614-b2c6-0eacfab7fcd2/
Source feed: FDA_Inspections

> FDA Inspection 637079 for Novartis Pharmaceuticals Corporation on December 10, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 637079
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2009-12-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 821628 - 2012-11-02](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/9a7e7a69-b289-435a-b3b6-70e41fdb1ec9/)
- [FDA Inspection 735205 - 2011-07-18](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/7c08f708-16fa-469e-a22c-c50dbbc083f5/)
- [FDA Inspection 725203 - 2011-05-12](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/8374ae24-a0ec-4c87-b907-926325b37ef9/)
- [FDA Inspection 678015 - 2010-08-27](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/c637a35d-3daa-475d-91a8-3886a5233215/)
- [FDA Inspection 589805 - 2009-05-13](https://www.globalkeysolutions.net/api/records/fda_inspections/novartis-pharmaceuticals-corporation/5c143de0-9181-4010-bae8-2497d24b93f6/)

Company: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/326f95cc-f2ac-4a21-8b19-5c99bd8ef53c

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d